HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$13.69
Day range
$13.57 - $14.11
Year range
$7.12 - $17.30
Market cap
242.11M USD
Avg Volume
99.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 36.84M | 42.32% |
Operating expense | 28.05M | 6.62% |
Net income | -1.03M | 84.39% |
Net profit margin | -2.80 | 89.02% |
Earnings per share | -0.06 | 85.00% |
EBITDA | 1.06M | 117.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 49.10M | -23.70% |
Total assets | 128.41M | 9.67% |
Total liabilities | 158.32M | 9.03% |
Total equity | -29.91M | — |
Shares outstanding | 17.59M | — |
Price to book | -8.05 | — |
Return on assets | 0.88% | — |
Return on capital | 1.59% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.03M | 84.39% |
Cash from operations | 302.00K | -94.91% |
Cash from investing | 10.93M | 267.98% |
Cash from financing | -752.00K | -101.61% |
Net change in cash | 10.48M | 22.89% |
Free cash flow | 549.25K | -92.61% |
About
Founded
1996
Headquarters
Website
Employees
147